US Patent Issued to Orionis Biosciences, VIB VZW, Universiteit Gent on Oct. 28 for "CLEC9A binding agents" (Belgian, American Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,453,770, issued on Oct. 28, was assigned to Orionis Biosciences BV (Ghent, Belgium), VIB VZW (Ghent, Belgium) and Universiteit Gent (Ghent, Belgium).

"CLEC9A binding agents" was invented by Jan Tavernier (Balegem, Belgium), Nikolai Kley (Newton, Mass.), Anje Cauwels (Merelbeke, Belgium) and Sarah Gerlo (Ghent, Belgium).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates, in part, to agents that bind C-type lectin domain containing 9A (Clec9A) and their use as diagnostic and therapeutic agents. The present invention further relates to pharmaceutical compositions comprising the Clec9A binding agents and their use in the treatment o...